Mallinckrodt Takes Out Sucampo in Surprising $1.2B Deal Post author:Sam Post published:December 26, 2017 Post category:BioPharma Mallinckrodt picks up Sucampo’s Amitiza as well as two other pipeline compounds. Source: BioSpace You Might Also Like 5 Healthcare Systems to Launch New Generic Drug Company January 17, 2018 Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals February 23, 2017 Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections March 25, 2018
Investors Breathe a Sigh of Relief Cempra's Skin Infection Drug Hits Phase III Goals February 23, 2017
